Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
Open Access
- 21 May 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (6)
Abstract
Since 2012, a single low dose of primaquine (SLDPQ; 0.25 mg/kg of body weight) with artemisinin-based combination therapies has been recommended as the first-line treatment of acute uncomplicated Plasmodium falciparum malaria to interrupt its transmission, especially in low-transmission settings of multidrug resistance, including artemisinin resistance. Policy makers in Cambodia have been reluctant to implement this recommendation due to primaquine safety concerns and a lack of data on its efficacy.Keywords
Funding Information
- International Division Fellowship Pasteur Paris
- FEI 5% (12INI211)
- Rotary Club (GG1523934)
- Dedonder Clayton (EC/MAM/N{degree sign}325/14)
This publication has 41 references indexed in Scilit:
- An innovative tool for moving malaria PCR detection of parasite reservoir into the fieldMalaria Journal, 2013
- Male and Female Plasmodium falciparum Mature Gametocytes Show Different Responses to Antimalarial DrugsAntimicrobial Agents and Chemotherapy, 2013
- G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patientsMalaria Journal, 2013
- Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infectioneLife, 2013
- The Effect of Primaquine on Gametocyte Development and Clearance in the Treatment of Uncomplicated Falciparum Malaria With Dihydroartemisinin-Piperaquine in South Sumatra, Western Indonesia: An Open-Label, Randomized, Controlled TrialClinical Infectious Diseases, 2012
- Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trialThe Lancet Infectious Diseases, 2010
- Heritability of the Human Infectious Reservoir of Malaria ParasitesPLOS ONE, 2010
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority TrialPLOS ONE, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008